Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
The Annals of Thoracic Surgery|June 17, 2021
Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung InjurySatoshi Nakao, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Respiratory Investigation|May 3, 2022
Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbationKakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, et al.
International Journal of Clinical Oncology|February 18, 2014
Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancerSeigo Miyoshi, Ryoji Ito, Hitoshi Katayama, et al.
BMC Cancer|April 14, 2017
MUC1 in lung adenocarcinoma: cross-sectional genetic and serological studyYasushi Horimasu, Nobuhisa Ishikawa, Sonosuke Tanaka, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 20, 2005
Successful treatment of obstructive sleep apnea syndrome improves autonomic nervous system dysfunctionRyoji Ito, Hironobu Hamada, Akihito Yokoyama, et al.
International Journal of Oncology|May 15, 2012
Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivoSeigo Miyoshi, Hironobu Hamada, Naohiko Hamaguchi, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2017
The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancerTakeshi Masuda, Chihiro Hirano, Yasushi Horimasu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
Docetaxel and cisplatin as second-line chemotherapy for advanced non-small cell lung cancerHironobu Hamada, Kazunori Irifune, Ryoji Ito, et al.
Experimental and Therapeutic Medicine|September 15, 2018
Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosisSachiko Shioya, Takeshi Masuda, Tadashi Senoo, et al.
Pageof 18